ESR1 and breast carcinoma: miR-222-3p, one of the top-ranked miRNAs detected in the model, has been shown to target the estrogen receptor 1 gene (ESR1) and was reported to be dramatically higher in ESR1 negative breast cancer cells, inhibiting ERα expression [39].